Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,058,371
+$177,841 QoQ
Shares Held
22,077
-7.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#514
of 1,348 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roehl & Yi Investment Advisors, LLC holds $14,211,884 across 9 Drug Manufacturers - General names. NVO ranks #3 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,711 | $6,783,792 | |
| 2 | AMGN |
Amgen Inc
|
48,313 | $2,042,778 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
22,077 | $1,058,371 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,486 | $961,951 | |
| 5 | ABBV |
AbbVie Inc.
|
3,171 | $797,950 | |
| 6 | PFE |
Pfizer Inc
|
31,305 | $753,824 | |
| 7 | LLY |
ELI LILLY & Co
|
626 | $750,843 | |
| 8 | AZN |
Astrazeneca PLC
|
3,863 | $732,502 |
All Filings in NVO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,058,371 | 22,077 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $880,530 | 23,960 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $780,143 | 15,333 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $963,361 | 17,361 | Shares | Sole | 2026-05-29 | |
| 2025-06-30 | $902,022 | 13,069 | Shares | Sole | 2026-05-29 | |
| 2025-03-31 | $880,082 | 12,674 | Shares | Sole | 2026-05-29 | |
| No filing history on record for this holder in this stock. | ||||||